chr19-3192637-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020170.4(NCLN):c.352G>A(p.Ala118Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000675 in 1,570,472 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020170.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCLN | NM_020170.4 | c.352G>A | p.Ala118Thr | missense_variant | 2/15 | ENST00000246117.9 | NP_064555.2 | |
NCLN | NM_001321463.2 | c.352G>A | p.Ala118Thr | missense_variant | 2/15 | NP_001308392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCLN | ENST00000246117.9 | c.352G>A | p.Ala118Thr | missense_variant | 2/15 | 1 | NM_020170.4 | ENSP00000246117.3 | ||
NCLN | ENST00000590671.5 | c.130G>A | p.Ala44Thr | missense_variant | 2/15 | 2 | ENSP00000466678.1 | |||
NCLN | ENST00000588428.5 | c.185-3546G>A | intron_variant | 5 | ENSP00000467011.1 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000291 AC: 6AN: 206032Hom.: 0 AF XY: 0.0000435 AC XY: 5AN XY: 114938
GnomAD4 exome AF: 0.0000691 AC: 98AN: 1418218Hom.: 0 Cov.: 32 AF XY: 0.0000542 AC XY: 38AN XY: 701414
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.352G>A (p.A118T) alteration is located in exon 2 (coding exon 2) of the NCLN gene. This alteration results from a G to A substitution at nucleotide position 352, causing the alanine (A) at amino acid position 118 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at